-
公开(公告)号:EP1778183B1
公开(公告)日:2018-06-27
申请号:EP05784837.6
申请日:2005-08-17
申请人: Synthon B.V.
IPC分类号: A61K9/08 , A61K31/4525 , A61K31/452 , A61K31/724
CPC分类号: A61K31/452 , A61K9/08 , A61K31/4525 , A61K31/724
摘要: A liquid paroxetine composition containing at least 5 mg/ml of paroxetine or a pharmaceutically acceptable salt thereof, a non-carbohydrate sweetener, and a solvent containing 60-100% of ethanol, polyol or mixtures and 0-40% of water, provides for good stability and taste.
-
公开(公告)号:EP1858855B1
公开(公告)日:2013-06-19
申请号:EP06723592.9
申请日:2006-03-16
申请人: Synthon B.V.
IPC分类号: C07D215/22
CPC分类号: C07D215/227
-
公开(公告)号:EP1778183A1
公开(公告)日:2007-05-02
申请号:EP05784837.6
申请日:2005-08-17
申请人: Synthon B.V.
IPC分类号: A61K9/08 , A61K31/4525
CPC分类号: A61K31/452 , A61K9/08 , A61K31/4525 , A61K31/724
摘要: A liquid paroxetine composition containing at least 5 mg/ml of paroxetine or a pharmaceutically acceptable salt thereof, a non-carbohydrate sweetener, and a solvent containing 60-100% of ethanol, polyol or mixtures and 0-40% of water, provides for good stability and taste.
摘要翻译: 含有至少5mg / ml帕罗西汀或其药学上可接受的盐,非碳水化合物甜味剂和含有60-100%乙醇,多元醇或混合物和0-40%水的溶剂的液体帕罗西汀组合物提供 良好的稳定性和口感。
-
公开(公告)号:EP1812397A1
公开(公告)日:2007-08-01
申请号:EP05810619.6
申请日:2005-11-17
申请人: Synthon B.V.
IPC分类号: C07D215/22
CPC分类号: C07D215/227
摘要: Crystalline aripiprazole Form B can be formed by crystallizing from a solvent selected from 1-propanol, 2-propanol, 1-butanol, ethyl acetate, acetonitrile or a combination thereof.
-
公开(公告)号:EP1812396A1
公开(公告)日:2007-08-01
申请号:EP05808062.3
申请日:2005-11-17
申请人: Synthon B.V.
IPC分类号: C07D215/22 , A61K31/4704 , A61P25/18
CPC分类号: C07D215/227
摘要: Alcoholates of aripiprazole are useful as pharmaceuticals and/or as intermediates in making aripiprazole Form A or Form B.
摘要翻译: 阿立哌唑的醇化物可用作制备阿立哌唑A型或B型的药物和/或中间体。
-
公开(公告)号:EP1858514B1
公开(公告)日:2014-11-26
申请号:EP06707624.0
申请日:2006-03-16
申请人: Synthon B.V.
发明人: ETTEMA, Gerrit, Jan, Bouke , WESTHEIM, Raymond, Jozef, Hubertus , KALMOUA, Faysal , JANSEN, Korinde, Annemarie , DORKOOSH, Farid, Abedin
IPC分类号: A61K31/4704 , A61K9/20 , A61K9/36
CPC分类号: A61K9/2018 , A61K9/2054 , A61K9/2077 , A61K31/4704 , A61K31/496 , C07D215/227 , Y10T428/2982
-
公开(公告)号:EP1858855A1
公开(公告)日:2007-11-28
申请号:EP06723592.9
申请日:2006-03-16
申请人: Synthon B.V.
IPC分类号: C07D215/22
CPC分类号: C07D215/227
摘要: Crystalline aripiprazole Type II can be formed without solid state heat treatment. Instead a liquid is used such as in crystallizing from a solvent, especially 2-propanol, dimethyl sulfoxide, tetrahydrofuran or a combination thereof, or in a solvent mediated solid-solid transformation, typically in ethyl acetate.
-
公开(公告)号:EP1858514A1
公开(公告)日:2007-11-28
申请号:EP06707624.0
申请日:2006-03-16
申请人: Synthon B.V.
发明人: ETTEMA, Gerrit, Jan, Bouke , WESTHEIM, Raymond, Jozef, Hubertus , KALMOUA, Faysal , JANSEN, Korinde, Annemarie , DORKOOSH, Farid, Abedin
IPC分类号: A61K31/4704 , A61K9/20 , A61K9/36
CPC分类号: A61K9/2018 , A61K9/2054 , A61K9/2077 , A61K31/4704 , A61K31/496 , C07D215/227 , Y10T428/2982
摘要: The invention relates to a pharmaceutical composition in the form of a tablet, comprising 1 to 50 mg of aripiprazole Type II and pharmaceutically acceptable excipients, said excipients including (a) one or more polyol fillers, (b) one or more binders, (c) one or more disintegrants, and (d) a lubricant.
-
-
-
-
-
-
-